Zobrazeno 1 - 10
of 20
pro vyhledávání: '"G Wilen-Rosenqvist"'
Autor:
J. Heikkinen, Anja Virkkunen, Fredrika Pekonen, Anna-Maija Rautio, Helena Sundström, Torsten Wahlström, Salmi T, Elina Granfors, Sakari Telimaa, Erkki Hirvonen, G. Wilen-Rosenqvist, J. Puolakka, Leo Mäkäräinen, Seppo Hulkko, Simo Nummi
Publikováno v:
Maturitas. 21:39-44
We evaluated whether a progestin, added for 14 days every 3 months to estrogen replacement therapy, is capable of preventing the development of endometrial hyperplasia in postmenopausal women during a treatment period of 2 years. Postmenopausal women
Autor:
J. E. Heikkinen, H. K. Väänänen, G. Wilen-Rosenqvist, J. H. V. Vanharanta, E. Kurttila-Matero, Kari S. Lankinen, Eero Kyllönen
Publikováno v:
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 7(5)
The purpose of this study was to examine the influence of estrogen-progestin replacement therapy and exercise on the lumbar spine mobility and back symptoms of early postmenopausal women. The population sample consisted of 78 healthy, 49- to 55-year-
Publikováno v:
British journal of obstetrics and gynaecology. 104
Objective To compare two doses of a transdermal oestradiol gel (Divigel®/Sandrena®) plus oral sequential medroxyprogesterone acetate (MPA) with oral oestradiol valerate plus oral sequential MPA (Divina®/Dilena®). Design Two-year, randomised, open
Publikováno v:
British journal of obstetrics and gynaecology. 104
Objective To compare the efficacy, safety and tolerability of an oestradiol gel (1.0 mg of oestradiol daily, Divigel®/Sandrena®) with those of an oestradiol delivering patch (delivering 50 μg oestradiol/24 h, Estraderm TTS®) in hormone replacemen
Autor:
Eero Kyllönen, Kari S. Lankinen, J. Heikkinen, Heli Rita, Eeva Kurttila-Matero, G. Wilen-Rosenqvist, H. Kalervo Väänänen
Publikováno v:
Maturitas. 26(2)
Objectives: To evaluate the effect of 1- or 3-monthly sequential combinations of estradiol valerate (E 2 V) and medroxyprogesterone acetate (MPA) on menopausal symptoms, bone density, muscle strength and lipid metabolism in postmenopausal women. Meth
Publikováno v:
Arzneimittel-Forschung. 43(9)
Erythromycin acistrate (Erasis, CAS 96128-89-1) is a 2'-acetyl ester prodrug of erythromycin. Due to prolonged half-life it is more suitable for twice daily dosing than the conventional erythromycin preparations. In the present double-blind trial, to
Publikováno v:
Maturitas. 27:119
Publikováno v:
Mononitrate II ISBN: 9783540178323
The clinical efficacy of isosorbide-5-mononitrate (IS-5-MN) and isosorbide dinitrate (ISDN) at different doses was compared in a double-blind cross-over study. In the study 12 men with a history of stable effort angina treated with sublingual nitrogl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::993603e3041f17a9b16606b9bf1cd298
https://doi.org/10.1007/978-3-642-72689-7_28
https://doi.org/10.1007/978-3-642-72689-7_28
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.